REPLIGEN CORP Accrued Royalties, Current
REPLIGEN CORP (RGEN) had Accrued Royalties, Current of $1.46 million as of 2021-12-31, per its 10-K filed 2022-02-17.
Discontinued › Notes › Payables and Accruals › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedRoyaltiesCurrent · last filed 2022-02-17
- 2021-12-31: Accrued Royalties, Current $1.46M.
- 2021-09-30: Accrued Royalties, Current $1.50M.
- 2021-06-30: Accrued Royalties, Current $1.21M.
- 2021-03-31: Accrued Royalties, Current $1.42M.
| Period end | Accrued Royalties, Current |
|---|---|
| 2021-12-31 | $1.46M 10-K · filed 2022-02-17 |
| 2021-09-30 | $1.50M 10-Q · filed 2021-10-28 |
| 2021-06-30 | $1.21M 10-Q · filed 2021-07-27 |
| 2021-03-31 | $1.42M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $466.00K 10-K · filed 2022-02-17 |
| 2020-09-30 | $1.00M 10-Q · filed 2020-11-05 |
| 2020-06-30 | $248.00K 10-Q · filed 2020-07-30 |
| 2020-03-31 | $887.00K 10-Q · filed 2020-05-06 |
| 2019-12-31 | $123.00K 10-K · filed 2021-02-24 |
| 2019-09-30 | $707.00K 10-Q · filed 2019-10-31 |
| 2019-06-30 | $163.00K 10-Q · filed 2019-08-01 |
| 2019-03-31 | $645.00K 10-Q · filed 2019-05-09 |
| 2018-12-31 | $242.00K 10-K · filed 2020-02-26 |
| 2018-09-30 | $1.06M 10-Q · filed 2018-11-01 |
| 2018-06-30 | $372.00K 10-Q · filed 2018-08-02 |
| 2018-03-31 | $1.24M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.38M 10-K · filed 2019-03-01 |
| 2017-09-30 | $1.06M 10-Q · filed 2017-11-09 |
| 2017-06-30 | $450.00K 10-Q · filed 2017-08-03 |
| 2017-03-31 | $857.00K 10-Q · filed 2017-05-04 |
| 2016-12-31 | $248.00K 10-K · filed 2018-02-22 |
| 2016-09-30 | $592.00K 10-Q · filed 2016-11-03 |
| 2015-12-31 | $7.00K 10-Q · filed 2016-11-03 |
| 2015-09-30 | $948.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $1.67M 10-Q · filed 2015-08-06 |
| 2015-03-31 | $882.51K 10-Q · filed 2015-05-08 |
| 2014-09-30 | $840.68K 10-Q · filed 2014-11-07 |
| 2014-06-30 | $7.26K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $560.50K 10-Q · filed 2014-05-09 |
| 2013-12-31 | $1.90M 10-K · filed 2015-03-17 |
| 2013-09-30 | $1.15M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.50M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $968.72K 10-Q · filed 2013-05-07 |
| 2012-12-31 | $1.46M 10-K · filed 2014-03-14 |
| 2012-09-30 | $1.08M 10-Q · filed 2012-11-08 |
| 2012-06-30 | $783.50K 10-Q · filed 2012-08-09 |
| 2011-12-31 | $499.78K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |